Posted by Michael Wonder on 13 Aug 2018
MS patient tells of stress of meeting PHARMAC criteria
14 August 2018 - When Auckland man Brendan Rochford stopped being able to walk 500 m unaided, he lost his access to the life-enhancing MS drug Tysabri.
The 41-year-old business analyst started on the drug when it was introduced in New Zealand three years ago and said since being on the medication the relapses that damaged his nervous system and caused a new disability have stopped.
"I was developing new lesions which are the marks on the brain that you can see in the MRI scan on a fairly regular basis and ever since I started Tysabri that has stopped."
